Form 13-F position report

CYTEIR THERAPEUTICS INC

Reported by D E Shaw & Co Inc

CYT CUSIP 23284P103 Manager CIK 0001009207

Reported 0 shares, down 58,529 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q3 2022
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 4 Through Q3 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 270000
2022-03-31 271000
2022-06-30 175000
2022-09-30 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

4 quarters
Quarterly reported position history for CYTEIR THERAPEUTICS INC held by D E Shaw & Co Inc.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2022 Reduced 0 -58,529 (-100.0%) 0 $0 2022-11-14
Q2 2022 Reduced 58,529 -13,330 (-18.6%) < 0.01% $175,000 2022-08-15
Q1 2022 Added 71,859 +48,146 (203.0%) < 0.01% $271,000 2022-05-16
Q4 2021 New 23,713 +23,713 (0.0%) < 0.01% $270,000 2022-02-14

Who else reported the position

45 managers reported CYTEIR THERAPEUTICS INC for Q3 2022.

Managers reporting CYTEIR THERAPEUTICS INC in Q3 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Novo Holdings A S Reduced 3,940,413 -900,000 0.36% $7,566,000 6 qtrs
FMR LLC Reduced 3,486,058 -386,231 < 0.01% $6,693,231 6 qtrs
BAKER BROS ADVISORS LP Unchanged 2,643,640 0 0.03% $5,076,000 6 qtrs
OUP Management Co LLC Reduced 2,469,572 -5,000 7.38% $4,742,000 4 qtrs
Avidity Partners Management LP Reduced 1,806,200 -43,800 0.07% $3,468,000 6 qtrs
CAAS CAPITAL MANAGEMENT LP Added 616,822 +536,938 0.06% $1,270,000 6 qtrs
Newtyn Management LLC Added 654,112 +47,864 0.28% $1,256,000 2 qtrs
VANGUARD GROUP INC Reduced 584,492 -27,106 < 0.01% $1,122,000 6 qtrs
Laurion Capital Management LP Unchanged 359,500 0 < 0.01% $690,000 2 qtrs
RENAISSANCE TECHNOLOGIES LLC Reduced 266,821 -80,521 < 0.01% $512,000 4 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2022
Filed
November 14, 2022
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.